NLRP3 inflammasome activation by estrogen promotes the progression of human endometrial cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• Wallace AE, Gibson DA, Saunders PT, Jabbour HN. Inflammatory events in endometrial adenocarcinoma. J Endocrinol. 2010;206(2):141–157. doi:10.1677/JOE-10-007220406782
   PubMed Web of Science ®Google Scholar
• Liu M, Zhang X. An integrated analysis of mRNA-miRNA transcriptome data revealed hub regulatory networks in three genitourinary cancers. Biocell. 2017;41(1):19–26.
   Web of Science ®Google Scholar
• Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev. 2015;265(1):6–21. doi:10.1111/imr.1229625879280
   PubMed Web of Science ®Google Scholar
• Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13(6):397–411. doi:10.1038/nri345223702978
   PubMed Web of Science ®Google Scholar
• von Moltke J, Ayres JS, Kofoed EM, Chavarria-Smith J, Vance RE. Recognition of bacteria by inflammasomes. Annu Rev Immunol. 2013;31:73–106. doi:10.1146/annurev-immunol-032712-09594423215645
   PubMed Web of Science ®Google Scholar
• Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature. 2012;481(7381):278–286. doi:10.1038/nature1075922258606
   PubMed Web of Science ®Google Scholar
• Mearini E, Poli G, Cochetti G, Boni A, Egidi MG, Brancorsini S. Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer. Onco Targets Ther. 2017;10:2665–2673. doi:10.2147/OTT.S13268028579804
   PubMed Web of Science ®Google Scholar
• Weichand B, Popp R, Dziumbla S, et al. S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1ß. J Exp Med. 2017;214(9):2695–2713. doi:10.1084/jem.2016039228739604
   PubMed Web of Science ®Google Scholar
• Karki R, Man SM, Kanneganti TD. Inflammasomes and cancer. Cancer Immunol Res. 2017;5(2):94–99. doi:10.1158/2326-6066.CIR-16-026928093447
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang L, Qiu M, et al. The protein levels of MCM7 and p63 in evaluating lesion severity of cervical disease. Int J Gynecol Cancer. 2013;23(2):318–324. doi:10.1097/IGC.0b013e31827f6f0623318911
   PubMed Web of Science ®Google Scholar
• Liu S, Hua T, Xin X, Shi R, Chi S, Wang H. Altered expression of hormone receptor, integrin ß3 and pinopode in the endometrium of luteal phase defect women. Gynecol Endocrinol. 2017;33(4):315–319. doi:10.1080/09513590.2016.125940527960568
   PubMed Web of Science ®Google Scholar
• Wei Q, Guo P, Mu K, et al. Estrogen suppresses hepatocellular carcinoma cells through ERß -mediated upregulation of the NLRP3 inflammasome. Lab Invest. 2015;95(7):804–816. doi:10.1038/labinvest.2015.6326006022
   PubMed Web of Science ®Google Scholar
• Ueno T, Yabushita H, Iwasaki K, Wakatsuki A. Role of adiponectin and leptin in non-diabetic, non-obese patients with endometrial cancer. Eur J Gynaecol Oncol. 2018;39(2):199–204.
   Web of Science ®Google Scholar
• Takiuchi T, Blake EA, Matsuo K, Sood AK, Brasky TM. Aspirin use and endometrial cancer risk and survival. Gynecol Oncol. 2018;148(1):222–232. doi:10.1016/j.ygyno.2017.10.02629132875
   PubMed Web of Science ®Google Scholar
• Verdoodt F, Friis S, Dehlendorff C, Albieri V, Kjaer SK. Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: a systematic review and meta-analysis of observational studies. Gynecol Oncol. 2016;140(2):352–358. doi:10.1016/j.ygyno.2015.12.00926701413
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang Y, Zhang X, Lv Y. Suspension state promotes extravasation of breast tumor cells by increasing integrin β1 expression. Biocell. 2018;42(1):17–24. doi:10.32604/biocell.2018.06115
   Web of Science ®Google Scholar
• He A, Shao J, Zhang Y, Lu H, Wu Z, Xu Y. CD200Fc reduces LPS-induced IL-1ß activation in human cervical cancer cells by modulating TLR4-NF-κB and NLRP3 inflammasome pathway. Oncotarget. 2017;8(20):33214–33224.28402258
   PubMedGoogle Scholar
• Wang Y, Kong H, Zeng X, et al. Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells. Oncol Rep. 2016;35(4):2053–2064. doi:10.3892/or.2016.456926782741
   PubMed Web of Science ®Google Scholar
• Dupaul-Chicoine J, Arabzadeh A, Dagenais M, et al. The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity. Immunity. 2015;43(4):751–763. doi:10.1016/j.immuni.2015.08.01326384545
   PubMed Web of Science ®Google Scholar
• Wei Q, Mu K, Li T, et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest. 2014;94(1):52–62. doi:10.1038/labinvest.2013.12624166187
   PubMed Web of Science ®Google Scholar
• Wang H, Wang Y, Du Q, et al. Inflammasome-independent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells. Exp Cell Res. 2016;342(2):184–192. doi:10.1016/j.yexcr.2016.02.01026968633
   PubMed Web of Science ®Google Scholar
• Berry KK, Varney ML, Dave BJ, Bucana CD, Fidler IJ, Singh RK. Expression of interleukin-8 in human metastatic endometrial carcinoma cells and its regulation by inflammatory cytokines. Int J Gynecol Cancer. 2001;11(1):54–60. doi:10.1046/j.1525-1438.2001.011001054.x11285034
   PubMed Web of Science ®Google Scholar
• Oh K, Lee OY, Park Y, Seo MW, Lee DS. IL-1ß induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells. BMC Cancer. 2016;16(1):724. doi:10.1186/s12885-016-2746-727609180
   PubMedGoogle Scholar
• Someya A, Ikegami T, Sakamoto K, Nagaoka I, Esteban FJ. Glucosamine downregulates the IL-1ß-induced expression of proinflammatory cytokine genes in human synovial MH7A cells by O-GlcNAc modification-dependent and -independent mechanisms. PLoS One. 2016;11(10):e0165158. doi:10.1371/journal.pone.016515827776166
   PubMed Web of Science ®Google Scholar
• Haring J, Skrzypczak M, Stegerer A, et al. Estrogen receptor ß transcript variants associate with oncogene expression in endometrial cancer. Int J Mol Med. 2012;29(6):1127–1136.22378275
   PubMed Web of Science ®Google Scholar
• Han SJ, Jung SY, Wu SP, et al. Estrogen receptor ß modlulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell. 2015;163(4):960–974. doi:10.1016/j.cell.2015.10.03426544941
   PubMed Web of Science ®Google Scholar
• Zendedel A, Mönnink F, Hassanzadeh G, et al. Estrogen attenuates local inflammasome expression and activation after spinal cord injury. Mol Neurobiol. 2018;55(2):1364–1375. doi:10.1007/s12035-017-0400-228127698
   PubMed Web of Science ®Google Scholar